• SENSEX 81,087.69
    -97.89 (--0.12%)
  • BANKNIFTY 55,617.60
    -344.35 (--0.62%)
  • Tata Motors
    647.20 542.55(%)
  • Axis Bank
    1,060.20 934.00(%)
  • Vimta Labs
    677.30 235.00(%)
  • GE Vernova T&D
    2,871.15 2,871.15(%)
  • Netweb Technol.
    2,299.15 3,060.00(%)
  • Suzlon Energy
    66.80 86.04(%)
  • Kaynes Tech
    6,483.00 7,824.95(%)
  • M & M
    3,117.25 2,360.45(%)
  • PNB Housing
    803.30 746.10(%)
  • Waaree Energies
    3,163.55 3,740.75(%)
  • HDFC Bank
    2,010.00 1,593.20(%)
  • Jayaswal Neco
    48.32 26.06(%)
  • Skipper
    548.00 665.00(%)
  • Shree Refrigerat
    177.70 177.70(%)
  • Timex Group
    244.75 289.90(%)
  • Hind. Unilever
    2,728.10 3,034.50(%)
  • TCS
    3,000.00 3,000.00(%)
  • Ceinsys Tech
    1,750.85 538.20(%)
  • Swiggy
    386.25 297.00(%)
  • KIOCL
    374.20 461.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

NGL Fine Chem Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 4558.0
  • ISIN : INE887E01022
1,313.00 -1 (-0.10%)
  • As on 02 Aug 2025 (EOD)

  • Today’s Low

    1,266.00

  • Today’s High

    1,345.90

  • Open

    1,345.90

  • Perv Close

    1,314.30

  • 52W Low

    957.00

  • 52W High

    2,736.90

Key Indicators

  • P/E(TTM)

    44.91

  • Mar.Cap (₹Cr.)

    811.43

  • Div & Yield %

    0.13

  • Book Value(₹)

    452.45

  • Debt-Equity Ratio

    -0.10

  • AGM Date

    01-Aug-2025

  • EPS

    29.34

  • P/E Ratio

    44.91

Financials Ratios

  • Debt-Equity Ratio

    0.14

  • Mar.Cap (₹Cr.)

    811.43

  • RONW (%)

    17.03

  • ROCE (%)

    20.16

Score Board

  • Equity (₹ in Cr.)

    3.09

  • BV (₹)

    452.50

  • Sales( ₹ in Cr.)

    359.29

  • NP (in Cr.)

    18.13

  • NP Var(%)

    -53.0

  • Div%

    35.0

  • CPS (₹)

    44.30

  • EPS (₹)

    29.30

  • Traded Value (₹ in Lakhs)

    814.40

  • 52 Week High

    2,736.90

  • 52 Week Low

    957.00

  • Price BSE

    1318.0

  • Price NSE

    1,313.00

  • Market Capital( in Cr.)

    814.40

  • P/C Ratio

    29.70

  • P/E Ratio

    44.90

  • Price Vs.BV

    29.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 359.29 328.97 275.05 318.67 258.18 152.18
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 359.29 328.97 275.05 318.67 258.18 152.18
Other Income 9.76 15.90 7.61 12.64 8.55 3.34
Stock Adjustments -1.36 12.06 -23.29 22.03 -1.86 5.39
Total Income 367.69 356.93 259.37 353.34 264.87 160.91
EXPENDITURE :            
Raw Materials 186.20 169.05 118.84 172.92 102.77 71.46
Power and Fuel Cost 20.48 18.60 15.45 14.47 9.27 9.75
Employee Cost 50.71 41.32 34.25 33.05 27.24 23.81
Other Manufacturing Expenses 53.17 47.44 37.17 41.21 26.49 18.50
Selling and Administration Expenses 15.33 14.51 11.24 8.56 11.52 7.94
Miscellaneous Expenses 5.47 5.34 6.09 4.57 1.98 5.19
Employee Benefit Expenses 50.71 41.32 34.25 33.05 27.24 23.81
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 331.37 296.27 223.05 274.77 179.27 136.66
Operating Profit 36.33 60.66 36.33 78.56 85.59 24.24
Interest 3.18 1.80 1.83 1.91 2.20 2.62
Gross Profit 33.15 58.86 34.50 76.65 83.39 21.62
Depreciation 9.27 8.15 7.90 7.67 7.39 7.27
Profit Before Tax 23.88 50.71 26.60 68.98 76.00 14.35
Current Tax 5.34 11.41 7.21 17.15 19.07 4.94
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.41 0.78 -0.73 -0.42 1.46 -1.19
Reported Net Profit 18.13 38.52 20.12 52.25 55.47 10.60
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 -1.49
Adjusted Net Profit 18.13 38.52 20.12 52.25 55.47 12.09
Adjustment below Net Profit -0.24 -0.15 -0.08 -0.05 -0.14 -0.44
P & L Balance brought forward 257.51 220.22 201.27 150.15 95.91 86.82
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 1.08 1.08 1.08 1.08 1.08 1.08
P & L Balance carried down 274.31 257.51 220.22 201.27 150.15 95.91
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 35.00 35.00 35.00 35.00 35.00 35.00
Dividend Per Share(Rs) 1.75 1.75 1.75 1.75 1.75 1.75
Earnings Per Share-Unit Curr 29.35 62.35 32.57 84.57 89.79 17.16
Earnings Per Share(Adj)-Unit Curr 29.35 62.35 32.57 84.57 89.79 17.16
Book Value 452.60 425.39 365.04 334.36 251.62 163.81
Book Value(Adj)-Unit Curr 452.60 425.39 365.04 334.36 251.62 163.81

Shareholding Pattern

  • Promoter Group

    72.74%

  • Public Share Holding

    27.26%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 4,493,646 72.74 4,493,646 5
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 4,493,646 72.74 4,493,646 5
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 20 0.00 20 1
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 62 0.00 62 2
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 82 0.00 82 3
2] Non Institution
Bodies Corporate 98,192 1.59 89,692 89
Clearing Members 6,017 0.10 6,017 11
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 52,762 0.85 52,762 409
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 102,347 1.66 102,347 281
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 50,000 0.81 50,000 1
Individuals holding nominal share capital up to Rs. 1 lakh 1,370,770 22.19 1,181,023 13,199
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 1,000 0.02 1,000 2
Others 0 0.00 0 0
Sub Total 1,684,296 27.26 1,485,749 14,002
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 6,178,024 100.00 5,979,477 14,010

Company Background

NGL Fine Chem LtdPharmaceuticals - Indian - Bulk Drugs

  • NGL Fine Chem Ltd
  • BSE Code : 4558.0
  • ISIN : INE887E01022

  • Incorporation Year

    1981

  • Registered Office

    301 E Square Subhash Road
    Vile Parle (East), Mumbai,
    Maharashtra-400057

  • Telephone

    +91-22-2663 6450

  • FAX

  • Chairman

    Dhananjay Mungale

  • Managing Director

    Rahul J Nachane

  • Company Secretary

    Pallavi Pednekar

  • Auditor

    Manek & Associates

  • Face Value

    5

  • Listing

    NSE

  • Registrar

    Purva Sharegistry (India) Pvt
    Shiv Shakti Indust,
    Unit No 9 Lower Pare,7 B J R Boricha Marg
    Mumbai - Mumbai-400011

NGL Fine Chem Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
NGL Fine Chem 1,317.80 369.05 359.29 44.91 8.20
Abbott India 33,676.00 6,684.73 6,409.15 50.59 44.95
Astrazeneca Phar 8,893.15 1,756.92 1,716.29 192.08 32.94
P & G Health Ltd 6,199.70 1,166.89 1,151.26 40.97 39.76
Glaxosmi. Pharma 2,933.90 3,866.05 3,723.49 52.76 58.72
Cipla 1,501.20 20,029.57 19,044.85 22.44 21.40
Amrutanjan Healt 676.35 437.58 421.23 38.47 20.84
Guj. Themis Bio. 371.85 174.19 169.82 90.92 44.82
Fermenta Biotec. 362.00 442.21 430.53 15.76 17.61
Bliss GVS Pharma 173.70 703.42 667.20 25.96 9.16
Ambalal Sarabhai 32.97 19.33 4.04 30.53 2.10